BRONCHIAL ASTHMA: EARLY CARDIOPULMONARY DYSFUNCTION
DOI:
https://doi.org/10.55640/Keywords:
Bronchial asthma; cardiopulmonary function; early functional disturbances; spirometry; electrocardiography; subclinical airway obstruction; cardiac dysrhythmia; hemodynamic load; individualized therapy; disease managementAbstract
Bronchial asthma (BA) is a chronic inflammatory disease of the airways, often associated with systemic manifestations affecting the cardiopulmonary system. The present study aimed to identify and evaluate early functional disturbances in the cardiopulmonary system of patients with BA. A cohort of patients with mild to moderate asthma underwent comprehensive assessments, including spirometry, electrocardiography, arterial blood pressure monitoring, and hemodynamic evaluation. Results revealed subclinical impairments in pulmonary ventilation, manifested by reductions in Forced Expiratory Volume in 1 second (FEV₁) and Peak Expiratory Flow (PEF), as well as early cardiac dysrhythmias and increased hemodynamic load. Correlation analyses demonstrated significant associations between disease duration, symptom severity, and functional alterations in both pulmonary and cardiac parameters. These findings underscore the systemic nature of BA, highlighting the importance of early detection, continuous monitoring, and individualized management strategies. Early interventions may prevent the progression of cardiopulmonary dysfunction, reduce the risk of complications, and improve overall patient outcomes. The study emphasizes the need for integrated cardiopulmonary evaluation in routine asthma care to optimize disease control and enhance quality of life.
Downloads
References
1.Belan, O. V. (2014). Cardiovascular comorbidities in patients with bronchial asthma. Russian Journal of Cardiology, 4(32), 45–52.
2.Greenberg, N. B. (2012). Systemic effects of chronic respiratory diseases. Journal of Pulmonology, 18(2), 101–108.
3.Ryabova, A. Yu. (2013). Interaction between metabolic syndrome and bronchial asthma. Clinical Medicine, 91(3), 27–34.
4.Solovyova, I. A. (2016). Early cardiopulmonary dysfunction in asthma patients. International Journal of Pulmonary Medicine, 12(1), 15–22.
5.Yakovleva, O. A. (2016). Autonomic nervous system involvement in obstructive pulmonary disease. Cardiopulmonary Research, 8(4), 56–63.
6.Bubnova, M. G. (2014). Pathophysiological mechanisms linking asthma and cardiovascular disease. Russian Journal of Clinical Medicine, 21(5), 42–49.
7.Vasilieva, T. S. (2013). Metabolic and cardiovascular comorbidities in bronchial asthma. Clinical Research in Pulmonology, 7(2), 34–40.
8.Pashkova, O. (2011). The role of the autonomic nervous system in bronchial obstruction. Journal of Pulmonary Pathophysiology, 3(1), 22–28.
9.Global Initiative for Asthma (GINA). (2024). Global Strategy for Asthma Management and Prevention (2024 update). Available from https://ginasthma.org/2024report/ Global Initiative for Asthma - GINA+2imsear.searo.who.int+2
10.Rajvanshi, N., Kumar, P., & Goyal, J. P. (2024). Global Initiative for Asthma Guidelines 2024: An Update. Indian Pediatrics, 61(8), 781786. imsear.searo.who.int
11.“How are asthma and heart health linked?” (2024, May 17). American Heart Association News. Available from https://www.heart.org/en/news/2024/05/17/how-are-asthma-and-heart-health-linked www.heart.org
12.Zhang, M., Guo, X., Guo, W., et al. (2025). “Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?” BMC Pulmonary Medicine, 25, 348.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India